Ceera Investments LLC Boosts Stock Holdings in Kenvue Inc. $KVUE

Ceera Investments LLC raised its holdings in Kenvue Inc. (NYSE:KVUE) by 131.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 150,249 shares of the company’s stock after acquiring an additional 85,205 shares during the period. Ceera Investments LLC’s holdings in Kenvue were worth $2,592,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of the business. Physician Wealth Advisors Inc. increased its stake in shares of Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares in the last quarter. Versor Investments LP grew its stake in Kenvue by 2.8% during the third quarter. Versor Investments LP now owns 26,016 shares of the company’s stock valued at $422,000 after acquiring an additional 716 shares in the last quarter. Philip James Wealth Mangement LLC grew its stake in Kenvue by 5.5% during the fourth quarter. Philip James Wealth Mangement LLC now owns 13,888 shares of the company’s stock valued at $240,000 after acquiring an additional 726 shares in the last quarter. Phoenix Financial Ltd. grew its stake in Kenvue by 5.4% during the fourth quarter. Phoenix Financial Ltd. now owns 15,195 shares of the company’s stock valued at $262,000 after acquiring an additional 783 shares in the last quarter. Finally, Titleist Asset Management LLC grew its stake in Kenvue by 1.6% during the third quarter. Titleist Asset Management LLC now owns 50,957 shares of the company’s stock valued at $827,000 after acquiring an additional 796 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.59% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

KVUE has been the subject of several recent analyst reports. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. UBS Group reduced their price objective on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and reduced their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Finally, Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus target price of $19.33.

Kenvue Trading Up 0.1%

Shares of Kenvue stock opened at $17.55 on Tuesday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $24.00. The firm has a market cap of $33.69 billion, a PE ratio of 20.64, a PEG ratio of 1.33 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The company has a 50 day simple moving average of $17.41 and a two-hundred day simple moving average of $17.44.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. During the same period in the previous year, the business posted $0.24 earnings per share. Kenvue’s revenue for the quarter was up 4.5% on a year-over-year basis. Analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.7%. Kenvue’s payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.